SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington’s Disease Phenotypes In Vivo - Bertin Instruments

    Scientific publications

    SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington’s Disease Phenotypes In Vivo

    Anna Bobrowska1, Gizem Donmez2¤, Andreas Weiss3, Leonard Guarente2, Gillian Bates1*
    Sources: 1 Department of Medical and Molecular Genetics, King’s College London, London, United Kingdom, 2 Paul F. Glenn Laboratory and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America, 3 Neuroscience Discovery, Novartis Institutes for BioMedical Research, Basel, Switzerland
    SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington’s Disease Phenotypes In Vivo. PLoS ONE 7(4): e34805. doi:10.1371/journal.pone.0034805

    Sample name

    Animal tissues (Mice Brain)

    ANY QUESTIONS? CONTACT AN EXPERT

    Please fill in this form if you wish to contact our sales team or receive further information.

    My Account
    Forgot password ?

    Add a question !

    Add a question